abcam-grey.png
Abcam Plc Results for the 12- and 18-month periods ended 31 December 2021
March 14, 2022 08:00 ET | Abcam
Growing demand for Abcam’s portfolio of in-house products drives calendar 2021 revenues up by 22% at constant exchange rates Acquisition of BioVision completed 26 October 2021 CAMBRIDGE, United...
abcam-grey.png
29% Constant Currency Revenue Growth in H2 as Lab Activity Gradually Recovers and Demand for Abcam In-house Products Increases
September 13, 2021 07:00 ET | Abcam
CAMBRIDGE, United Kingdom, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; AIM: ABC) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research...
abcam-grey.png
Abcam to Acquire BioVision for $340 million
August 02, 2021 02:00 ET | Abcam
CAMBRIDGE, United Kingdom, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM LSE: ABC; Nasdaq: ABCM) ("Abcam", “the Company” or "the Group"), a global leader in the supply of life science research...
abcam-grey.png
Abcam and MEDx extend precision medicine strategic partnership
April 12, 2021 05:00 ET | Abcam
Building on existing three-year collaborationFocusing on co-development of companion and in vitro diagnostic kits to support demand in China CAMBRIDGE, United Kingdom and SHANGHAI, China, April 12,...
abcam-grey.png
Abcam Wins Industry Awards from CiteAb
March 24, 2021 07:49 ET | Abcam
CAMBRIDGE, United Kingdom, March 24, 2021 (GLOBE NEWSWIRE) -- Today Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life science reagents and tools, announced that Dr Alejandra Solache, SVP of...
abcam-grey.png
8.3% constant currency revenue growth in H1 as customers gradually return to labs
March 08, 2021 07:00 ET | Abcam
CAMBRIDGE, United Kingdom, March 08, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; AIM: ABC) (“Abcam”, the “Group” or the “Company”), a global leader in the supply of life science research...
abcam-grey.png
Abcam Expands Presence in China to Support Increased Demand of BioPharma Sector
March 04, 2021 04:00 ET | Abcam
Scaling up R&D, manufacturing and commercial capabilities in Shanghai and Hangzhou Investing in state-of-the-art facilities and equipment to support research, diagnostic and clinical applications ...
Abcam to Report Interim Results on Monday, March 8, 2021
February 26, 2021 02:00 ET | Abcam
CAMBRIDGE, United Kingdom, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC; Nasdaq: ABCM) (“Abcam” or the “Company”), a global leader in the supply of life science research tools, will report...
Abcam to present at the 2021 SVB Leerink Global Healthcare Conference
February 17, 2021 07:00 ET | Abcam
CAMBRIDGE, United Kingdom, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; LSE: ABC) today announced that Alan Hirzel, Chief Executive Officer, will present at the 2021 SVB Leerink Global...
Abcam Plc Appointment of Non-Executive Directors
January 28, 2021 02:00 ET | Abcam
CAMBRIDGE, United Kingdom, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC; Nasdaq: ABCM) (“Abcam”), a global leader in the supply of life science research tools, is delighted to announce the...